PD-L1 plays an immunosuppressive role by binding to PD-1 in T cells, with blockage of this interaction capable of effectively reversing T cell inhibition and avoiding immunosuppression in the tumor microenvironment (Benson et al., 2010; Yu et al., 2019). Here, CD274 is linked to neoplasm.